Eliran Mor, MD is currently the Medical Director at the California Center for Reproductive Health. CCRH has three office locations in Southern California: Encino, West Hollywood, and Valencia. Dr. Mor is a Reproductive Endocrinologist who works in cooperation with his staff to create a caring and healing environment for all of his patients. He also endeavors to make CCRH a safe space for transgender patients and those from the LGBTQIA community.
Before becoming the medical director, Dr. Mor began his medical career by receiving his medical degree from the University of Tel Aviv-Sackler College of Medicine. He then completed a four-year residency in obstetrics and gynecology at the New York Methodist Hospital in Brooklyn, New York, before finishing a three-year fellowship in reproductive endocrinology and infertility at the University of Southern California.
In addition to the duties associated with the California Center for Reproductive Health, Dr. Mor is also a clinical instructor at the University of Southern California.
Eliran Mor, MD became a licensed medical professional in the state of California in 2001 and is also certified by the American Board of Obstetrics and Gynecology in obstetrics and gynecology and reproductive endocrinology and infertility. Dr. Mor is a member in excellent standing of a number of prestigious medical associations including the American Society of Reproductive Medicine (ASRM), the Pacific Coast Reproductive Society (PCRS), the Society of Laparoendoscopic Surgeons (SLS), and the American College of Obstetricians and Gynecologists (ACOG).
Dr. Mor also is a published researcher and author, having been published at least a dozen times in a variety of peer-reviewed medical journals. A few of the ttles include: ”Gonadotroph adenoma and resulting ovarian hyperstimulation: A report of three cases” in Fertility and Sterility; “Pregnancy in the sixth decade of life: Obstetrical outcomes in women of advanced reproductive age” in the Journal of the American Medical Association; and “Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population” in the Journal of Assisted Reproduction and Genetics.
In order to learn about the latest treatments and research in his field, Dr. Mor also tries to attend at least two medical conferences or meetings in person every year. Dr. Mor has also presented or co-presented abstracts at these meetings. Dr. Mor’s abstract entitled, “Insulin resistance in polycystic ovary syndrome: Clinical implications of fasting glucose and insulin levels” was awarded the Frank Lynch Memorial Essay Award. It was presented at the 70th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, September 16-21, 2003 in Anchorage, Alaska. Another of his abstracts entitled, “Defective autophosphorylation of the insulin receptor (APIR): A potential mechanism of insulin resistance in polycystic ovary syndrome (PCOS)” was presented at the 59th Annual Meeting of the American Society for Reproductive Medicine, October 11-15, 2003 in San Antonio, Texas. This abstract was presented with the Society for Reproductive Endocrinology and Infertility Fellowship Research Prize Paper Award.
As a true patient’s doctor, Eliran Mor, MD has been named a “Most Compassionate Doctor” by the American Registry. His compassion is evident to patients and their loved ones as soon as they are seen by Dr. Mor. He believes in providing patients with the information and support they need to make informed choices about their own care.
Dr. Mor is a very involved doctor when dealing with individuals and families that are struggling to start or expand their families. All consultations, after-hour inquiries, pelvic examinations, ultrasound examinations, diagnostic procedures, assisted reproductive procedures (egg retrievals, embryo transfers…), and surgical procedures, if needed, will be performed by Dr. Mor. Involvement in every aspect of his patients’ fertility care and complete micromanagement of their treatment makes Dr. Mor the ideal partner on a patient’s path to becoming pregnant.